logo
North Carolina's first standalone children's hospital set to bring 8,000 jobs to a Raleigh suburb

North Carolina's first standalone children's hospital set to bring 8,000 jobs to a Raleigh suburb

APEX, N.C. (AP) — North Carolina's first standalone children's hospital will be built in a bedroom community near the state capital, the project's health systems announced Thursday, creating a campus estimated to bring 8,000 jobs to the area.
UNC Health and Duke Health announced in January an agreement to jointly build the proposed 500-bed pediatric hospital and linked facilities in the state's Research Triangle region, which includes Raleigh, Durham and Chapel Hill.
At that time, the specific location wasn't finalized. But leaders of the health systems said Thursday that the 'North Carolina Children's' project will be constructed about 20 miles (32.19 kilometers) southwest of downtown Raleigh in Apex, a town of 77,000 already surging in population thanks to the region's strong technology economy.
The 230-acre (93.1-hectare) campus will also include a children's outpatient care center, over 100 behavioral health beds and a research and education center operated by Duke University and University of North Carolina medical schools.
The campus is poised to be integrated into a long-discussed mixed-use development location called Veridea that will include thousands of new homes, retail, dining, office and research space, as well as a new Wake Technical Community College campus.
'This campus will create a brighter, healthier future for generations of children and adolescents across North Carolina and the Southeast, and we're thrilled to have Apex as our home and partner,' UNC Heatlh CEO Dr. Wesley Burks said in a news release.
A groundbreaking for the hospital campus is now expected in 2027, with construction anticipated to take six years. North Carolina Children's Health also issued on Thursday a request for information from potential design and construction contractors for the project.
There are children's hospitals already in North Carolina, including those operated by the University of North Carolina and Duke University health systems that are attached to their main campuses in the Triangle.
The Apex location 'will ensure that the Triangle remains a hub and a destination for the best pediatric scientists, teachers and clinicians — convenient to both medical school campuses,' said Dr. Mary Klotman, dean of the Duke University medical school and a Duke Health executive.
The health systems have said the hospital campus project could cost from $2 billion to $3 billion, with a massive private fundraising effort ahead.
The project has already received $320 million from state legislators. The next state budget, still being negotiated by House and Senate Republicans that ultimately would head to Democratic Gov. Josh Stein's desk, also could contain more project funds.
Stein said in an interview Thursday that beyond the economic opportunity the project will spark, 'I'm really excited about what the children's hospital means for children of North Carolina who are sick and in need of the best, most sophisticated, advanced medical interventions to live long, healthy lives.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UnitedHealth Group names new CFO
UnitedHealth Group names new CFO

Yahoo

time11 minutes ago

  • Yahoo

UnitedHealth Group names new CFO

UnitedHealth Group has appointed Wayne DeVeydt as its new chief financial officer (CFO), succeeding John Rex. Rex, having served as CFO since 2016, will transition to a strategic advisory role to the CEO. UnitedHealth chairman and CEO Stephen Hemsley said: 'John Rex has been an exceptional leader, having helped guide our company through substantial change with both strategic vision and strong commitment to our mission. I look forward to his continued insights as UnitedHealth Group moves forward. 'Wayne DeVeydt combines deep financial acumen and operating experience with the mission-oriented and compassionate approach to healthcare that is a perfect fit for UnitedHealth Group.' With a background in healthcare finance and operations, DeVeydt's experience includes his recent tenure as a managing director and operating partner at Bain Capital. Prior to Bain, he served as chairman and CEO of Surgery Partners, where he oversaw the company's operational scope between 2018 and 2020. He held the position of CFO at Anthem (now Elevance) from 2007 to 2016, having joined the company in 2005. Prior to his time at Anthem, he was a partner at PricewaterhouseCoopers, focusing on healthcare. DeVeydt stated: 'There is no organisation besides UnitedHealth Group that presents the kinds of opportunities to make a difference in healthcare, from individual patient care to broad system efficiency, so I am eagerly looking forward to joining the team. 'I have been fortunate to know John Rex for over two decades and am honoured to follow a leader of his calibre.' In May, Hemsley was named CEO of UnitedHealth following the departure of Andrew Witty due to personal reasons. "UnitedHealth Group names new CFO " was originally created and published by Life Insurance International, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

Quadria Group Appoints Namit Chugh as Director to Strengthen Health-tech Investment Focus
Quadria Group Appoints Namit Chugh as Director to Strengthen Health-tech Investment Focus

Entrepreneur

time12 minutes ago

  • Entrepreneur

Quadria Group Appoints Namit Chugh as Director to Strengthen Health-tech Investment Focus

You're reading Entrepreneur India, an international franchise of Entrepreneur Media. HealthQuad, the healthcare-focused growth venture capital platform of Quadria Group, has appointed Namit Chugh as Director, marking a strategic move to bolster its investment approach in deep-tech and tech-enabled healthcare models. Chugh brings over 15 years of experience in healthtech investing and consulting. Welcoming the appointment, Dr Amit Varma, Co-founder of HealthQuad, said, "We are excited to welcome Namit to the HealthQuad team. His ability to identify and scale early-stage ventures with real-world healthcare impact aligns strongly with our mission. Namit brings fresh perspectives, deep sector insight, and a sharp founder-first mindset, qualities that will further strengthen our approach to identifying and nurturing the next wave of healthcare disruptors in India." Before joining HealthQuad, Chugh was Principal at W Health Ventures, an early-stage healthtech fund where he was part of the founding team. He played a central role in shaping the India and India–US corridor investment strategy, leading investments in companies such as Wysa, BeatO, and Mylo. He was also involved in the creation of 2070 Health, the venture studio arm of W Health Ventures, supporting tech-enabled companies at the seed stage and establishing India's only seed-to-venture healthtech platform. Earlier in his career, Chugh worked with Lok Capital, where he executed and exited investments across healthcare, consumer-tech, and insurtech, including Dr Mohan's Diabetes Center and Renewbuy. He also held roles at consulting firms Alvarez & Marsal and PwC, focusing on healthcare strategy and transaction advisory. At HealthQuad, Chugh will be responsible for identifying high-impact growth venture opportunities in areas such as artificial intelligence and other advanced technologies in healthcare, strengthening founder engagement, and driving thematic investment strategies. His appointment comes as HealthQuad expands its focus in high-growth sectors including healthtech, medtech, biopharma, and digitally enabled care. The expansion is supported by the recently launched HealthQuad Fund III, targeting up to USD 200 million with an additional USD 100 million option. Sunil Thakur, Co-founder of HealthQuad, noted, "Namit's track record of backing differentiated healthcare startups, combined with his operational rigor and ecosystem understanding, makes him a strong strategic addition to our leadership. His experience in cross-border models and thematic innovation will complement our vision as we double down on backing category-defining ventures in India and beyond." Reflecting on his new role, Chugh said, "Joining HealthQuad at this exciting phase is a natural next step in my journey of backing meaningful healthcare innovation. The team's conviction in supporting companies solving India's critical healthcare challenges resonates deeply with my own. I look forward to contributing towards building scalable, tech-enabled, and impactful healthcare models that improve access and outcomes for millions."

Michael Heinley Joins Sam Brown Healthcare Communications As Managing Director, Client Development and Engagement
Michael Heinley Joins Sam Brown Healthcare Communications As Managing Director, Client Development and Engagement

Associated Press

time13 minutes ago

  • Associated Press

Michael Heinley Joins Sam Brown Healthcare Communications As Managing Director, Client Development and Engagement

WAYNE, Pa. & NEW YORK--(BUSINESS WIRE)--Aug 4, 2025-- Sam Brown Healthcare Communications, a Blue Matter Company, is proud to announce the appointment of Michael Heinley to the new position of Managing Director, Client Development and Engagement, reporting to Founder and President Laura Liotta. This press release features multimedia. View the full release here: Michael Heinley With deep in-house and agency PR experience in the life sciences industry, Heinley is a highly seasoned counselor with a proven record of strategic communications impact across leading global organizations. These include senior leadership roles at Johnson & Johnson, Merck & Co., Inc., and WebMD. Most recently, as Senior Partner in the Finn Partners Global Health Practice, he led client development and engagement for pharmaceutical, biotech, health tech, med tech, health systems, professional societies, and advocacy organizations. 'In today's fast-moving and complex healthcare environment, Michael has a distinct perspective leading corporate, scientific, marketing, and brand storytelling campaigns that build trust, strengthen reputation, and deliver meaningful business results,' said Laura Liotta, Founder and President of Sam Brown. 'In this new role at Sam Brown, Michael will be instrumental in delivering innovative solutions, expanding our services and markets globally, and enabling our integrated teams to help clients adapt and lead in an evolving landscape.' Throughout his career, Heinley oversaw multiple global pharmaceutical product launches, R&D communications, employee engagement, financial/IR communications, reputation and issues management, CEO and C-suite counsel, and executive thought leadership. Heinley was named among the industry's most influential leaders and Mentor of the Year by PM360. He currently serves on the Board of Directors for Donate Life New York State, a statewide nonprofit dedicated to increasing organ and tissue donation. 'I'm thrilled to join the talented team at Sam Brown to help drive the agency's continued growth and success,' said Heinley. 'Under Laura's leadership, I've deeply admired the 'Sam Brownie' culture—recognized for building and sustaining enduring client partnerships through strategic expertise, hands-on senior counsel, and integrated creative excellence.' About Sam Brown Healthcare Communications For 26 years, Sam Brown has been a leading healthcare-focused corporate, clinical, and commercial communications agency for the life sciences industry. Sam Brown provides broad strategic communications services to a wide range of biotechnology, biopharmaceutical, and venture capital companies whose cutting-edge science and innovation impact human health. For more information, visit About Blue Matter Blue Matter is a strategic consulting firm serving the life sciences industry. From its offices in North America, Europe and Asia, Blue Matter serves pharmaceutical and biotech companies from around the globe. The firm helps clients maximize value at the product, portfolio, and organization levels. It has broad therapeutic expertise with a focus on complex markets such as oncology, CNS, and rare diseases. For more information, visit View source version on CONTACT: Media Contact: Christy Curran Sam Brown Inc. 615.414.8668 [email protected] KEYWORD: UNITED STATES NORTH AMERICA PENNSYLVANIA NEW YORK INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL PUBLIC RELATIONS/INVESTOR RELATIONS GENERAL HEALTH HEALTH CONSULTING COMMUNICATIONS PROFESSIONAL SERVICES SOURCE: Sam Brown Healthcare Communications Copyright Business Wire 2025. PUB: 08/04/2025 07:30 AM/DISC: 08/04/2025 07:30 AM

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store